Calyxt Reports Third Quarter 2022 Financial Results and Prov

—Successfully produced squalene, an important ingredient for personal care products and vaccine adjuvants— —Continued to progress customer acquisition...

Related Keywords

United States , Canaccord Genuity , Kimberly Minarovich Cameron Willis , Gerry Nuovo , Brennan Burks , Michaela Carr , Calyxt Inc , Technology Platform , Current Customer Projects Under Development , Chemistries Under Development For Potential Customers , Nasdaq , Calyxt Business Development Contact , Payroll Protection Program , Toll International , Company Biofactory , Scale Of Calyxt Proprietary Technology , Business Development , Evologic Technologies , Plant Cell Matrix , Calyxt Engineered Plant Cell Matrix , Chief Executive Officer , Calyxt Engineered Plant Cell , Customer Projects Under Development , First Global Infrastructure Partner , Enable Growth , Evologic Technologies Gmbh , Membership Inclusion , Three Months Ended September , Common Warrants , Open Market Sale Agreement , Bill Koschak , Chief Financial Officer , Media Contact , Investor Relations Contact , Cameron Willis , Business Development Contact , Vice President , Securities Litigation Reform Act , Annual Report , Except Par Value , Share Amounts , Thousands Except Shares , Per Share Amounts , Calyxt , Nc ,